These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 10417017

  • 41. Efforts by commercial health plans to increase Chlamydia trachomatis screening among their members.
    Atherly A, Blake SC.
    Sex Transm Dis; 2013 Jan; 40(1):55-60. PubMed ID: 23254117
    [Abstract] [Full Text] [Related]

  • 42. The cost effectiveness of screening for genital Chlamydia trachomatis infection in Australia.
    Walleser S, Salkeld G, Donovan B.
    Sex Health; 2006 Dec; 3(4):225-34. PubMed ID: 17112432
    [Abstract] [Full Text] [Related]

  • 43. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy.
    Blackwell AL, Thomas PD, Wareham K, Emery SJ.
    Lancet; 1993 Jul 24; 342(8865):206-10. PubMed ID: 8100930
    [Abstract] [Full Text] [Related]

  • 44. Cost-Effectiveness of Opt-Out Chlamydia Testing for High-Risk Young Women in the U.S.
    Owusu-Edusei K, Hoover KW, Gift TL.
    Am J Prev Med; 2016 Aug 24; 51(2):216-224. PubMed ID: 26952078
    [Abstract] [Full Text] [Related]

  • 45. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
    van Valkengoed IG, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ.
    Int J Epidemiol; 2004 Apr 24; 33(2):416-25. PubMed ID: 15082651
    [Abstract] [Full Text] [Related]

  • 46. Screening pregnant women in the 2015 European guideline on the management of Chlamydia trachomatis infections.
    Joseph Davey D, Medline A, Klausner JD.
    Int J STD AIDS; 2016 Oct 24; 27(12):1134-1136. PubMed ID: 27694561
    [No Abstract] [Full Text] [Related]

  • 47. Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado family planning clinics.
    Humphreys JT, Henneberry JF, Rickard RS, Beebe JL.
    Sex Transm Dis; 1992 Oct 24; 19(1):47-53. PubMed ID: 1561588
    [Abstract] [Full Text] [Related]

  • 48. Cost-effectiveness of screening swab or urine specimens for Chlamydia trachomatis from young Canadian women in Ontario.
    Goeree R, Jang D, Blackhouse G, Chong S, Mahony J, Sellors J, Foy A, Chernesky M.
    Sex Transm Dis; 2001 Dec 24; 28(12):701-9. PubMed ID: 11725225
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. The cost effectiveness of opportunistic chlamydia screening in England.
    Adams EJ, Turner KM, Edmunds WJ.
    Sex Transm Infect; 2007 Jul 24; 83(4):267-74; discussion 274-5. PubMed ID: 17475686
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Screening for Chlamydia trachomatis Infections in Women.
    Wiesenfeld HC.
    N Engl J Med; 2017 Feb 23; 376(8):765-773. PubMed ID: 28225683
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Chlamydia trachomatis in pregnant women in the county of Vestsjaelland. Prevalence, prevention of perinatal transmission and cost-effectiveness of screening].
    Ottesen M, Sahl I, Herbstman MM, Friis HM, Philipsen T.
    Ugeskr Laeger; 1996 Feb 05; 158(6):756-8. PubMed ID: 8638313
    [Abstract] [Full Text] [Related]

  • 55. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies.
    Howell MR, Quinn TC, Gaydos CA.
    Ann Intern Med; 1998 Feb 15; 128(4):277-84. PubMed ID: 9471930
    [Abstract] [Full Text] [Related]

  • 56. Effectiveness and cost-effectiveness of a pharmacy-based screening programme for Chlamydia trachomatis in a high-risk health centre population in Amsterdam using mailed home-collected urine samples.
    van Bergen JE, Postma MJ, Peerbooms PG, Spangenberg AC, Tjen-A-Tak J, Bindels PJ.
    Int J STD AIDS; 2004 Dec 15; 15(12):797-802. PubMed ID: 15601485
    [Abstract] [Full Text] [Related]

  • 57. Enhanced chlamydia surveillance in New South Wales (Australia) prisons, 2005-2007.
    Forrest G, Boonwaat L, Douglas J, Awofeso N.
    Int J Prison Health; 2009 Dec 15; 5(4):233-40. PubMed ID: 25757524
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
    Blake DR, Gaydos CA, Quinn TC.
    Sex Transm Dis; 2004 Feb 15; 31(2):85-95. PubMed ID: 14743071
    [Abstract] [Full Text] [Related]

  • 60. Estimation of the burden of disease and costs of genital Chlamydia trachomatis infection in Canada.
    Tuite AR, Jayaraman GC, Allen VG, Fisman DN.
    Sex Transm Dis; 2012 Apr 15; 39(4):260-7. PubMed ID: 22421691
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.